For instance, CircPRRX1 was shown to promote doxorubicin resistance in gastric cancer by inhibiting miR-3064-5p and enhancing protein tyrosine phosphatase, non-receptor type 14 (PTPN14) signaling [27]. This evidence concerns the gene PTPN14 and gastric cancer.